Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment
Victoria Neely(Virginia Commonwealth University), Hisashi Harada(Virginia Commonwealth University)
Cited by 11
Related Papers
Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer
|Cell Death and Disease|2014|88
Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells
|Cell Death and Disease|2012|69